BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1674659)

  • 1. Diacylglycerol production in Jurkat T-cells: differences between CD3, CD2 and PHA activation pathways.
    Pelassy C; Mary D; Aussel C
    Cell Signal; 1991; 3(1):35-40. PubMed ID: 1674659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral T-lymphocyte activation by human T-cell leukemia virus type I interferes with the CD2 but not with the CD3/TCR pathway.
    Dodon MD; Bernard A; Gazzolo L
    J Virol; 1989 Dec; 63(12):5413-9. PubMed ID: 2573739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakdown of a phosphatidylcholine pool arising from the metabolic conversion of phosphatidylethanolamine as a novel source of diacylglycerol in activated T cells.
    Aussel C; Pelassy C; Rossi B
    J Lipid Mediat; 1990; 2(2):103-16. PubMed ID: 2135667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation.
    Stohl W; Linker-Israeli M
    Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation.
    Carabasi MH; DiSanto JP; Yang SY; Dupont B
    Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of T lymphocytes via monoclonal antibodies against rat cell surface antigens with particular reference to CD2 antigen.
    Beyers AD; Barclay AN; Law DA; He Q; Williams AF
    Immunol Rev; 1989 Oct; 111():59-77. PubMed ID: 2576418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do CD2 and CD3-TCR T-cell activation pathways function independently?
    Kabelitz D
    Immunol Today; 1990 Feb; 11(2):44-7. PubMed ID: 1970736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of phosphotyrosyl polypeptides in normal and leukemic human T lymphocytes activated via CD3 or CD2.
    Boyer C; Ley S; Davies A; Crumpton M
    Mol Immunol; 1993 Jul; 30(10):903-10. PubMed ID: 7688073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of MAP-2 kinase activity by the CD2 receptor in Jurkat T cells can be reversed by CD45 phosphatase.
    Nel AE; Ledbetter JA; Williams K; Ho P; Akerley B; Franklin K; Katz R
    Immunology; 1991 Jun; 73(2):129-33. PubMed ID: 1676984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of human T lymphocytes through CD3 and CD2 (T11) with anti-CD3-coupled sheep erythrocytes.
    Ocklind G
    Scand J Immunol; 1988 May; 27(5):609-13. PubMed ID: 2897712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
    Suthanthiran M
    J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phosphatidic acid-sensitive intracellular pool of calcium is released by anti-CD3 in Jurkat T cells.
    Breittmayer JP; Aussel C; Farahifar D; Cousin JL; Fehlmann M
    Immunology; 1991 Jun; 73(2):134-9. PubMed ID: 1649123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of CD2-negative T cells by staphylococcal enterotoxin superantigens.
    Duan XC; Kabelitz D
    Immunol Lett; 1991 Aug; 29(3):219-22. PubMed ID: 1685147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule.
    Gerli R; Bertotto A; Crupi S; Arcangeli C; Marinelli I; Spinozzi F; Cernetti C; Angelella P; Rambotti P
    J Immunol; 1989 Apr; 142(8):2583-9. PubMed ID: 2564856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell response to anti-CD2 monoclonal antibodies in Down's syndrome.
    Bertotto A; Crupi S; Arcangeli C; Gerli R; Marinelli I; Velardi A; Vaccaro R
    Scand J Immunol; 1989 Jul; 30(1):39-43. PubMed ID: 2569229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessory cell-dependent T-cell activation via Ti-CD3. Involvement of CD2-LFA-3 interactions.
    Halvorsen R; Leivestad T; Gaudernack G; Thorsby E
    Scand J Immunol; 1988 Sep; 28(3):277-84. PubMed ID: 2461580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
    Huet S; Boumsell L; Dausset J; Degos L; Bernard A
    Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.
    Hofmann B; Jakobsen KD; Odum N; Dickmeiss E; Platz P; Ryder LP; Pedersen C; Mathiesen L; Bygbjerg IB; Faber V
    J Immunol; 1989 Mar; 142(6):1874-80. PubMed ID: 2564029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell activation via the CD2 molecule is associated with protein kinase C translocation from the cytosol to the plasma membrane.
    Bagnasco M; Nunes J; Lopez M; Cerdan C; Pierres A; Mawas C; Olive D
    Eur J Immunol; 1989 May; 19(5):823-7. PubMed ID: 2567674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-dependent regulation of phosphatidylserine synthesis in control and activated Jurkat T cells.
    Aussel C; Pelassy C; Mary D; Breittmayer JP; Cousin JL; Rossi B
    J Lipid Mediat; 1991; 3(3):267-81. PubMed ID: 1685336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.